S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

AWH Aspira Womans Health Inc

0.8085

0.031 (3.99%)

21 Dec 2024 - Closed

Delayed by 15 minutes

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Aspira Womans Health (NASDAQ:AWH)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Aspira Womans Health Charts.

Aspira Womans Health (NASDAQ:AWH)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Aspira Womans Health Charts.

Aspira Womans Health Inc News

Form 8-K - Current report
Tuesday 17 December 2024 (6 days ago) • Edgar (US Regulatory)

Aspira Women’s Health Announces Appointment of Dr. Sandra Milligan as Interim CEO
Tuesday 17 December 2024 (6 days ago) • GlobeNewswire Inc.

Aspira Women’s Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award
Wednesday 4 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Saturday 23 November 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 20 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (1 month ago) • Edgar (US Regulatory)

Aspira Women’s Health Reports Selected Third Quarter 2024 Financial Results
Friday 15 November 2024 (1 month ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Aspira Women’s Health Expands Co-Marketing and Distribution Collaboration with BioReference® to Include OvaWatch®
Friday 8 November 2024 (1 month ago) • GlobeNewswire Inc.

More Aspira Womans Health Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions